U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07164326) titled 'Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients' on Aug. 30.

Brief Summary: Dexmedetomidine nebulization in sever preeclamptic patients

Study Start Date: Oct. 15

Study Type: INTERVENTIONAL

Condition: Pressor Response

Intervention: DRUG: Dexmedetomidine

Nebulization of dexmedetomidine

DRUG: Saline

Nebulization of normal saline

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided by (Responsible Party): Mohamed Sayed Hussein Hassan, Assiut University

Published by HT Digital Content Services with p...